Across TCGA pan-cancer cohorts, RBM7P1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RBM7P1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RBM7P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RBM7P1 is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

HNSC, PAAD, and COAD are the cancer types where RBM7P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RBM7P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.055	.006	5	view →
PAAD	All	All	−0.175	.048	2	view →
COAD	All	All	+0.141	.013	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RBM7P1 RNA expression & survival · all RBM7P1 data types